Provided by Tiger Trade Technology Pte. Ltd.

Achieve Life Sciences, Inc.

8.17
+0.23002.90%
Post-market: 8.170.00000.00%16:10 EDT
Volume:1.32M
Turnover:10.85M
Market Cap:838.72M
PE:-4.92
High:8.42
Open:8.04
Low:8.01
Close:7.94
52wk High:8.61
52wk Low:2.62
Shares:102.66M
Float Shares:73.95M
Volume Ratio:0.78
T/O Rate:1.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6600
EPS(LYR):-1.2535
ROE:-844.99%
ROA:-29.21%
PB:-57.15
PE(LYR):-6.52

Loading ...

Press Release: Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma

Dow Jones
·
May 12

Press Release: Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 11

Achieve Life Sciences Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
May 08

Achieve Life Sciences to report Q1 results, host earnings call and webcast

Reuters
·
May 05

Achieve Life Sciences posts corporate deck on cytisinicline nicotine dependence treatment launch plan

Reuters
·
May 04

Achieve Life Sciences files Form 3 initial beneficial ownership for TPG GP A LLC

Reuters
·
Apr 25

Achieve Life Sciences director Lucian Iancovici files initial beneficial ownership statement

Reuters
·
Apr 25

Achieve Life Sciences CEO Andrew D. Goldberg files initial beneficial ownership statement

Reuters
·
Apr 22

Achieve Life Sciences Initiated at Buy by Canaccord Genuity

Dow Jones
·
Apr 21

Canaccord Genuity Initiates Coverage on Achieve Life Sciences With Buy Rating, $13 Price Target

MT Newswires Live
·
Apr 21

Achieve Life Sciences initiated with a Buy at Canaccord

TIPRANKS
·
Apr 21

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV), Decibel Cannabis Company (OtherDBCCF) and Eli Lilly & Co (LLY)

TIPRANKS
·
Apr 17

Achieve Life Sciences announces $354M private placement

TIPRANKS
·
Apr 16

BUZZ-Achieve Life Sciences rises as it names new CEO ahead of key drug launch

Reuters
·
Apr 16

Achieve Life Sciences names Andrew Goldberg CEO, adds him to board

Reuters
·
Apr 16

Press Release: Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

Dow Jones
·
Apr 16

Achieve Life Sciences announces unregistered private placement raising up to $354 million

Reuters
·
Apr 16

Achieve Life Sciences Inc - Appoints Andrew D. Goldberg as CEO and Board Member Effective After Closing

THOMSON REUTERS
·
Apr 16

Achieve Life Sciences - Proceeds to Fund Phase 3 Clinical Trial for Cytisinicline for E-Cigarette Cessation, Commercialization of Cytisinicline

THOMSON REUTERS
·
Apr 16